These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 9092362)

  • 21. [Lupus nephritis: retrospective analysis of the course of the disease].
    Djukanović L; Pavlović S; Blagojević R; Dimitrijević J; Stojsic T; Ratković M; Kazić K; Lezaić V; Naumović R
    Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():26-31. PubMed ID: 12583310
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of lupus nephritis.
    Austin HA; Balow JE
    Semin Nephrol; 2000 May; 20(3):265-76. PubMed ID: 10855936
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The efficacy of intravenous pulse cyclophosphamide in the treatment of severe lupus nephritis in children.
    Tangnararatchakit K; Tapaneya-Olarn C; Tapaneya-Olarn W
    J Med Assoc Thai; 1999 Nov; 82 Suppl 1():S104-10. PubMed ID: 10730528
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Beyond immunosuppression - challenges in the clinical management of lupus nephritis.
    Masood S; Jayne D; Karim Y
    Lupus; 2009 Feb; 18(2):106-15. PubMed ID: 19151111
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic factors in lupus nephritis: diagnostic and therapeutic delay increases the risk of terminal renal failure.
    Faurschou M; Starklint H; Halberg P; Jacobsen S
    J Rheumatol; 2006 Aug; 33(8):1563-9. PubMed ID: 16881113
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment for lupus nephritis: a revisit.
    Lai KN; Tang SC; Mok CC
    Nephrology (Carlton); 2005 Apr; 10(2):180-8. PubMed ID: 15877679
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lupus nephritis.
    Sauter M; Anders HJ
    Minerva Med; 2007 Dec; 98(6):749-58. PubMed ID: 18299686
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic options for critically ill patients suffering from progressive lupus nephritis or Goodpasture's syndrome.
    Merkel F; Netzer KO; Gross O; Marx M; Weber M
    Kidney Int Suppl; 1998 Feb; 64():S31-8. PubMed ID: 9475486
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The difference between lupus nephritis class IV-G and IV-S in Koreans: focus on the response to cyclophosphamide induction treatment.
    Kim YG; Kim HW; Cho YM; Oh JS; Nah SS; Lee CK; Yoo B
    Rheumatology (Oxford); 2008 Mar; 47(3):311-4. PubMed ID: 18204087
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Euro-Lupus Nephritis Trial: the development of the sequential treatment protocol.
    D'Cruz DP; Houssiau FA
    Lupus; 2009 Sep; 18(10):875-7. PubMed ID: 19671785
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Renal replacement therapy in lupus nephritis.
    Moroni G; Tantardini F; Ponticelli C
    J Nephrol; 2003; 16(6):787-91. PubMed ID: 14736005
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lupus nephritis: classification, clinical features, and treatment.
    Weissleder R; Galarza DA; Garza MA
    Rev Invest Clin; 1987; 39(3):263-76. PubMed ID: 3324251
    [No Abstract]   [Full Text] [Related]  

  • 33. Prospective multicentre trial on the short-term effects of plasma exchange versus cytotoxic drugs in steroid-resistant lupus nephritis.
    Derksen RH; Hené RJ; Kallenberg CG; Valentijn RM; Kater L
    Neth J Med; 1988 Oct; 33(3-4):168-77. PubMed ID: 3067098
    [No Abstract]   [Full Text] [Related]  

  • 34. [Lupus nephropathy: difficulties in its treatment].
    Flores JC
    Rev Med Chil; 1989 Aug; 117(8):930-6. PubMed ID: 2519456
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lupus nephritis: a clinical review for practicing nephrologists.
    Contreras G; Roth D; Pardo V; Striker LG; Schultz DR
    Clin Nephrol; 2002 Feb; 57(2):95-107. PubMed ID: 11863131
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The treatment of LED-nephritis].
    Mustonen J
    Duodecim; 1994; 110(11):1090-5. PubMed ID: 7588119
    [No Abstract]   [Full Text] [Related]  

  • 37. Update on immunosuppressive therapy in human and experimental glomerulonephritis.
    Jacquot C; Baran D; Vendeville B; Pelletier L; Druet P
    Adv Nephrol Necker Hosp; 1988; 17():77-99. PubMed ID: 3124553
    [No Abstract]   [Full Text] [Related]  

  • 38. Rapid improvement in severe lupus glomerular lesions following intensive plasma exchange associated with immunosuppression.
    Talwalkar YB; Nakamura T
    Clin Nephrol; 1987 Feb; 27(2):102. PubMed ID: 3829475
    [No Abstract]   [Full Text] [Related]  

  • 39. Progress in the treatment of proliferative lupus nephritis.
    Balow JE; Austin HA
    Curr Opin Nephrol Hypertens; 2000 Mar; 9(2):107-15. PubMed ID: 10757214
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Nephrology 2010].
    Zidek W
    Dtsch Med Wochenschr; 2010 Jun; 135(25-26):1275-7. PubMed ID: 20556681
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.